Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma

D.L. Lildballe, K.Q.T. Nguyen, S.S. Poulsen, H.O. Nielsen, E. Nexo

Open source

DOI
10.1016/j.ejso.2010.11.001
Published
2011-01
Container
European Journal of Surgical Oncology (EJSO)
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejso.2010.11.001,
  title = {Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma},
  author = {D.L. Lildballe and K.Q.T. Nguyen and S.S. Poulsen and H.O. Nielsen and E. Nexo},
  year = {2011},
  journal = {European Journal of Surgical Oncology (EJSO)},
  doi = {10.1016/j.ejso.2010.11.001},
  url = {https://doi.org/10.1016/j.ejso.2010.11.001}
}

RIS

TY  - JOUR
TI  - Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma
AU  - D.L. Lildballe
AU  - K.Q.T. Nguyen
AU  - S.S. Poulsen
AU  - H.O. Nielsen
AU  - E. Nexo
PY  - 2011
JO  - European Journal of Surgical Oncology (EJSO)
DO  - 10.1016/j.ejso.2010.11.001
UR  - https://doi.org/10.1016/j.ejso.2010.11.001
ER  - 

APA

Lildballe, D., Nguyen, K., Poulsen, S., Nielsen, H., & Nexo, E. (2011). Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO). https://doi.org/10.1016/j.ejso.2010.11.001

Source records